← SynDRA
SGC-0946
SynDRA canonical compound SYN0079682 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- DOT1L INHIBITOR
- histone lysine methyltransferase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- TP53
- BRD4
- ASH1L
- SMARCA4
- KAT2A
- KAT2B
- PBRM1
- PHIP
- SMARCA2
- SP140
- CECR2
- SP140L
- TAF1
- TAF1L
- TRIM24
- TRIM28
- HDAC6
- BRWD3
- ATAD2
- BRWD1
- BRPF3
- BRPF1
- BRDT
- BRD9
- BRD3
- BRD2
- BRD1
- BPTF
- BAZ2B
- BAZ2A
- BAZ1A
- ATAD2B
- TRIM66
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CBP
- CP2C9
- CP3A7
- KSYK
- NSD2
- SYK
Cross-references
Synonyms
- SGC 0946
- SGC0946
- CHEMBL3087498
- 5-Bromo-7-{5-[(3-{[(4-Tert-Butylphenyl)carbamoyl]amino}propyl)(Propan-2-Yl)amino]-5-Deoxy-Beta-D-Ribofuranosyl}-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine
- 1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea
- MLS006011035
- C28H40BrN7O4
- GTPL7020
- SCHEMBL17433345
- AOB3554
- EX-A321
- MolPort-028-720-498
- ZINC97956664
- s7079
- BDBM50443016
- 2714AH
- AKOS024458211
- Sgc0946
- RefChem:182669
- MFCD26523136
- AW2
- orb1304559
- SCHEMBL29352994
- CHEBI:232383
- SGC-0946?
- CCG-270251
- CS-3531
- EBC-510421
- NCGC00344622-01
- NCGC00344622-10
- NCGC00344622-13
- AC-32710
- BS-15720
- BS174968
- HY-15650
- SMR004702828
- SGC0946, >=98% (HPLC)
- SW219393-1
- F870105
Look up SGC-0946 in the interactive SynDRA portal →